Skip to content
FIND A HEALTH VALLEY ACTOR

HUG Innovation Day: four projects awarded

Journée Innovation HUG Oct 2026

On 15 October 2026, the Geneva University Hospitals (HUG) held the 20th edition of their Innovation Day. The event connects hospital, academic and economic players to help ideas from the field reach patients, and in some cases become patents or industrial products. From the bedside to the market, four projects were awarded. Thirteen projects were…

Read More

Ready to Sell? Deep Dive at Biopôle

Deep Dive -Turning Commercial

Ready to sell? What it really takes to go from innovation to commercialisation.Your product is approved. Now what? On 5 October 2026, BioAlps and Biopôle brought about 40 founders, investors and ecosystem partners together at Biopôle in Lausanne for a Deep Dive on one of the hardest steps in a life sciences company’s journey: the…

Read More

Les Sciences de la Vie – Une Force à Préserver

On 27 November 2026, at IMD Lausanne, several experts will discuss the future of Western Switzerland Life Sciences sector. Life sciences are not just an important sector. They have become one of the pillars of our regional and national economy. What have we built, what is currently under pressure, and what must we absolutely preserve…

Read More

Gondola Medical Technologies: proven science, hard road to adoption

Gondola Medical

Gondola Medical Technologies, a medtech company with roots in Ticino and Vaud, has been granted a four-month debt-restructuring moratorium (sursis concordataire) by the Lausanne District Court. The moratorium runs until 5 February 2027, as announced in the Swiss Official Gazette of Commerce (FOSC). Founded in Lugano in 2011, Gondola moved two years later to Biopôle…

Read More

Swiss Health Valley on La Matinale RTS

La Matinale - RTS

On 14 October, Magali Bischof, Secretary General of Swiss Health Valley by BioAlps, was the guest of La Matinale on RTS La 1ère. The question on the table: are life sciences the new golden goose of French-speaking Switzerland? “No, it’s not an exaggeration,” she answered. “But it’s not new either. This industry has been present…

Read More

Life sciences in the Swiss Health Valley: CHF 28 billion and counting

Sciences de la vie

How much do life sciences really weigh in the economy of Western Switzerland? A new study answers that for the first time in a systematic way. BAK Economics wrote it for the Groupement Romand de l’Industrie Pharmaceutique (GRIP), was published earlier this week. It covers the cantons of Bern, Fribourg, Geneva, Jura, Neuchâtel, Vaud and…

Read More

Boehringer Ingelheim Horizon HealthTech Startup Challenge

Health Tech Startup Challenge

Applications are now open for the Boehringer Ingelheim Horizon HealthTech Startup Challenge. Apply before 3 January 2027. The programme is looking for startups developing AI-powered and data-driven healthcare solutions to advance predictive analytics, early detection, and integrated care in cardiovascular, renal, and metabolic diseases. The challenge focuses on solutions in : The programme is looking…

Read More

Baio Labs receives CHF 150,000 from Venture Kick

Baio Labs

The EPFL spin-off Baio Labs has obtained CHF 150,000 from Venture Kick to advance its generative AI platform for early-stage drug discovery. By designing novel molecules for specific therapeutic targets in seconds, the biotech startup aims to help researchers identify promising drug candidates faster and at significantly lower cost. Finding new drug candidates traditionally involves…

Read More

Ilmac Lausanne 2026: a Record Edition and a Packed BioAlps Forum

Ilmac 2026

On 24 of September, BioAlps Swiss Health Valley organised a one-day forum at Ilmac Lausanne and attracted overs 300 participants. Ilmac Lausanne, held on 23 and 24 September 2026 at Beaulieu, had its best edition yet. The event welcomed 3,952 participants (+18.6% compared with 2024) and 213 exhibitors (+7%), further strengthening its position as an…

Read More

Innowwide

Innowwide

Apply before 1 December 2026 for Innowwide, a programme supported by Eureka to assess market feasability Innowwide supports innovative small and medium sized enterprises (SMEs) and start-ups to assess the viability of research or commercial plans in international markets. The Eureka programme offers grants of 60’000 euro for market feasibility projects in cooperation with local…

Read More